INVAInnoviva, Inc.

$1B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$261M+0.0% YoY

Gross Profit

$261M100.0% margin

Operating Income

$246M94.4% margin

Net Income

$157M60.3% margin

EPS (Diluted)

$1.43

Cash Flow

Operating Cash Flow

$257M

Free Cash Flow

$257M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$725M

Total Liabilities

$383M

Stockholders' Equity

$313M

Cash & Equivalents

$278M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$261M	$261M	+0.0%
Gross Profit	$261M	$261M	+0.0%
Operating Income	$246M	$238M	+3.4%
Net Income	$157M	$395M	-60.2%

INVA FY 2019 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena